Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Average Weight Loss in the Orforglipron phase 3 ATTAIN-1 Trial Across the 72-week study period, participants: Lost up to 15% of their body weight at the highest dose At 36 mg: 54.6% lost 10%, 36.0% lost 15%, 18.4% lost 20% body weight (all higher than placebo)
"The staff is great
Such an estimation brings allulose intake close to that of fructose from added sugars in European countries (Reference Azas-Braesco, Sluik and Maillot6)
Tkalcevi, V
US$ 25.93
US$ 27.69
US$ 28.05
US$ 21.28
US$ 28.07
